Drug information for LARODOPA

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 100MG Discontinued   LEVODOPA Levodopa ROCHE 16912
CAPSULE; ORAL 250MG Discontinued   LEVODOPA Levodopa ROCHE   "
CAPSULE; ORAL 500MG Discontinued   LEVODOPA Levodopa ROCHE   "
TABLET; ORAL 100MG Discontinued   LEVODOPA Levodopa ROCHE   "
TABLET; ORAL 250MG Discontinued   LEVODOPA Levodopa ROCHE   "
TABLET; ORAL 500MG Discontinued   LEVODOPA Levodopa ROCHE   "

Drug Adverse Effects information for LARODOPA

Role code Indications Reaction # Reports
C PARKINSON'S DISEASE BLOOD CREATINE PHOSPHOKINASE INCREASED 2
C PARKINSON'S DISEASE BLOOD CREATININE INCREASED 1
C PARKINSON'S DISEASE BLOOD UREA INCREASED 1
C PARKINSON'S DISEASE C-REACTIVE PROTEIN INCREASED 1
C PARKINSON'S DISEASE DYSKINESIA 1
C PARKINSON'S DISEASE NEUROLEPTIC MALIGNANT SYNDROME 2
C PARKINSON'S DISEASE PYREXIA 2
C PARKINSON'S DISEASE RENAL FAILURE 1
C PARKINSON'S DISEASE SOMNOLENCE 1
C PARKINSON'S DISEASE WHITE BLOOD CELL COUNT INCREASED 1
Ads by Google